Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien

Stefan F Cordes, MD, PhD, Morie A Gertz, M.D., Francis K Buadi, MD, Yi Lin, MDPhD, Martha Q Lacy, MD, Prashant Kapoor, MD, Shaji K Kumar, MD, Arleigh McCurdy, MD, Angela Dispenzieri, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, William J. Hogan, MBChB, Rajiv K Pruthi, MBBS

Blood (2013) 122 (21): 2151.

https://doi.org/10.1182/blood.V122.21.2151.2151

Published: 2013

Journal Articles

Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience

Jonas Paludo, MD, Utkarsh Painuly, MD, Shaji Kumar, MD, Francis Buadi, MD, Suzanne R Hayman, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, John A. Lust, MD, PhD, David Dingli, M.D., Ph.D., Arleigh McCurdy, MD, Stephen J. Russell, MD, PhD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, Vincent Rajkumar, MD, Morie A Gertz, M.D., Robert Kyle, MD, MACP, Prashant Kapoor, MD

Blood (2013) 122 (21): 3119.

https://doi.org/10.1182/blood.V122.21.3119.3119

Published: 2013

Journal Articles

Mass Spectrometry-Based Proteomics Reveals Distinct Immunoglobulin Light Chain Variable Region Usage In Systemic Versus Localized AL Amyloidosis

Oana M Mereuta, M.D., Ph.D., Surendra Dasari, Ph.D, Jason D Theis, BS, Julie A Vrana, Ph.D., Karen L Grogg, M.D., Morie A Gertz, M.D., Steven R. Zeldenrust, M.D., Ph.D., Angela Dispenzieri, MD, Marina Ramirez-Alvarado, Ph.D., Diane F. Jelinek, PhD, Paul J Kurtin, MD, Ahmet Dogan, MD, PhD

Blood (2013) 122 (21): 3142.

https://doi.org/10.1182/blood.V122.21.3142.3142

Published: 2013

Journal Articles

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Angela Dispenzieri, MD, Amy K. Saenger, M.D., Shaji K. Kumar, MD, Morie A. Gertz, M.D., Martha Q Lacy, MD, Francis Buadi, MD, Suzanne R Hayman, MD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, Arleigh McCurdy, MD, Robert Kyle, MD, MACP, David Dingli, M.D., Ph.D., Prashant Kapoor, MD, Yi Lin, MDPhD, Stephen J. Russell, MD, PhD, Ronald S. Go, MD, Allan S. Jaffe, M.D.

Blood (2013) 122 (21): 3095.

https://doi.org/10.1182/blood.V122.21.3095.3095

Published: 2013

Journal Articles

Proteome Of Amyloidosis: Mayo Clinic Experience In 4139 Cases

Jason D Theis, BS, Surendra Dasari, Ph.D, Julie A Vrana, Ph.D., Oana M Mereuta, M.D., Ph.D., Karen L Grogg, M.D., Morie A Gertz, M.D., Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Paul J Kurtin, MD, Ahmet Dogan, MD, PhD

Blood (2013) 122 (21): 1900.

https://doi.org/10.1182/blood.V122.21.1900.1900

Published: 2013

Journal Articles

Lenalidomide Maintenance Therapy In Multiple Myeloma: A Meta-Analysis Of Randomized Trials

Preet Paul Singh, MD, Shaji K Kumar, MD, Betsy R. LaPlant, Morie A Gertz, M.D., Angela Dispenzieri, MD, P. Leif Bergsagel, MD, Martha Q Lacy, MD, Siddharth Singh, MD, Vivek Roy, M.D., Francis K Buadi, MD, David Dingli, M.D., Ph.D., Robert Kyle, MD, MACP, S. Vincent Rajkumar, MD, Prashant Kapoor, MD

Blood (2013) 122 (21): 407.

https://doi.org/10.1182/blood.V122.21.407.407

Published: 2013

Journal Articles

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

Stephen M Ansell, M.D., Ph.D., Frank J Secreto, Ph.D., Michelle Manske, Esteban Braggio, Ph.D., Lucy S. Hodge, PharmD, Ph.D., Tammy Price-Troska, Steven C. Ziesmer, Asher Alban Chanan-Khan, M.D., Morie A Gertz, M.D., Ahmet Dogan, MD, PhD, James R Cerhan, MD, PhD, Anne J Novak, Ph.D.

Blood (2012) 120 (21): 2699.

https://doi.org/10.1182/blood.V120.21.2699.2699

Published: 2012

Journal Articles

Outcomes of Patients with POEMS Syndrome Treated Initially with Radiation

Michael Humeniuk, M.D., Morie A. Gertz, M.D., Martha Q. Lacy, MD, Robert A. Kyle, MD, Suzanne R. Hayman, MD, Shaji K. Kumar, MD, John A. Lust, MD, PhD, Thomas E. Witzig, MD, Francis K. Buadi, M.D., S. Vincent Rajkumar, MD, Steven R. Zeldenrust, MD, PhD, Stephen J. Russell, MD, PhD, David Dingli, M.D., Ph.D., Yi Lin, MD, Prashant Kapoor, MD, Nelson Leung, MD, Angela Dispenzieri, MD

Blood (2012) 120 (21): 448.

https://doi.org/10.1182/blood.V120.21.448.448

Published: 2012

Journal Articles

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

Shahrukh Hashmi, MD, MPH, Chintan Pandya, MD MPH, Morie A Gertz, M.D., Angela Dispenzieri, MD, William Hogan, MD, Mustaqeem A Siddiqui, MD, Nandita Khera, MD, Katia Noyes, MS MPH PhD, Shaji K. Kumar, MD

Blood (2012) 120 (21): 602.

https://doi.org/10.1182/blood.V120.21.602.602

Published: 2012

Journal Articles

Importance of Achieving Sustained Stringent Complete Response (sCR) Following Autologous Stem Cell Transplantation in Multiple Myeloma

Prashant Kapoor, MD, Morie A Gertz, M.D., Angela Dispenzieri, MD, Martha Q Lacy, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, Francis K Buadi, M.D., Stephen Russell, MD, PhD, Yi Lin, MD, Thomas E. Witzig, MD, John A Lust, MD, PhD, Steven R Zeldenrust, MD, PhD, Philip R. Greipp, MD, Robert A. Kyle, MD, Vincent Rajkumar, MD, Shaji K. Kumar, MD

Blood (2012) 120 (21): 1988.

https://doi.org/10.1182/blood.V120.21.1988.1988

Published: 2012

Journal Articles

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Sumit Madan, M.D., Angela Dispenzieri, M.D., Martha Q. Lacy, MD, Francis Buadi, M.D., Suzanne R. Hayman, MD, Kristin Detweiler, R.N., C.N.P, Steven R. Zeldenrust, M.D., Ph.D., David Dingli, M.D., PhD., Philip R Greipp, M.D., Stephen J. Russell, MD, PhD, John A. Lust, MD, PhD, Robert A Kyle, MD, S. Vincent Rajkumar, M.D., Morie A Gertz, M.D., Shaji K Kumar, MD

Blood (2009) 114 (22): 4867.

https://doi.org/10.1182/blood.V114.22.4867.4867

Published: 2009

Journal Articles

Melphalan and Dexamethasone Is Less Effective for Patients with Immunoglobulin Light Chain Amyloidosis (AL) with High Bone Marrow Plasmacytosis.

Nelson Leung, MD, Heidi D Gunderson, Pharm.D., Tow S Tan, MD, CM, Angela Dispenzieri, MD, Morie A Gertz, M.D., Steven R Zeldenrust, MD, PhD, Martha Q Lacy, MD, Francis K Buadi, MBChB, Suzanne R. Hayman, MD, Shaji Kumar, MD

Blood (2008) 112 (11): 1735.

https://doi.org/10.1182/blood.V112.11.1735.1735

Published: 2008

Journal Articles

Immunoglobulin Free Light Chain Ratio Is an Independent Risk Factor for Progression of Smoldering Multiple Myeloma.

Angela Dispenzieri, MD, Robert A. Kyle, M.D., Jerry A. Katzmann, Ph.D., Dirk Larson, Joanne Benson, Raynell Clark, L. Joseph Melton, Ph.D., Morie A. Gertz, M.D., Shaji K. Kumar, M.D, Rafael Fonseca, M.D., Diane F. Jelinek, Ph.D, S. Vincent Rajkumar, M.D.

Blood (2007) 110 (11): 1487.

https://doi.org/10.1182/blood.V110.11.1487.1487

Published: 2007

NARROW

Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien

Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience

Mass Spectrometry-Based Proteomics Reveals Distinct Immunoglobulin Light Chain Variable Region Usage In Systemic Versus Localized AL Amyloidosis

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Proteome Of Amyloidosis: Mayo Clinic Experience In 4139 Cases

Lenalidomide Maintenance Therapy In Multiple Myeloma: A Meta-Analysis Of Randomized Trials

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

Outcomes of Patients with POEMS Syndrome Treated Initially with Radiation

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

Importance of Achieving Sustained Stringent Complete Response (sCR) Following Autologous Stem Cell Transplantation in Multiple Myeloma

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Melphalan and Dexamethasone Is Less Effective for Patients with Immunoglobulin Light Chain Amyloidosis (AL) with High Bone Marrow Plasmacytosis.

Immunoglobulin Free Light Chain Ratio Is an Independent Risk Factor for Progression of Smoldering Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only